Cue Biopharma Inc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (15)

View All

Latest Posts

About This Stock More About This Stock
The Truth About IPO Investing
Article By: Marc Lichtenfeld
Saturday, September 2, 2023 12:39 PM EDT
When most companies go public, they are somewhat mature. Tech company initial public offerings, or IPOs, are a bit different, however. These companies are often not yet profitable. And biotech IPOs are a special animal altogether.
In this article: SLRN, ABBV Also: PLSE, CUE
Read
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More
Article By: Benzinga
Sunday, January 23, 2022 2:45 PM EDT
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the frenetic pace of the week that encompassed the JPM Healthcare conference.
In this article: ABT, JNJ, RHHBY, UCBJY, ZGNX, VRTX, ZLAB, CUE, DCPH, ETON
Read
Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million Deal
Article By: ChinaBio® Today
Saturday, October 17, 2020 1:14 PM EDT
Curon Biopharma, a Shanghai clinical-stage in-licensing company, acquired China rights to Tenalisib, a dual PI3K delta and gamma inhibitor, from Rhizen Pharma. Rhizen will receive milestone payments worth up to $149.5 million, plus royalties.
In this article: LLY, LGND, CUE, ASLN, TXG
Read
The Week Ahead In Biotech (Aug. 30- Sept. 5): Bristol-Myers Squibb FDA Decision, Adcom Review For Glaxo, Amarin Vascepa Hearing
Article By: Benzinga
Sunday, August 30, 2020 5:36 PM EDT
Biotech stocks went about a consolidation move in the week ended August 28 amid thin news flow. Barring updates on coronavirus vaccine/treatment candidates, there was very little for the sector to react to.
In this article: AZN, BMY, GSK, NVS, ACST, INCY, ARWR, CUE, ORTX, AEZS
Read
5 Stocks To Soar In 2020 After Solid Gains In 2019
Article By: Zacks Investment Research
Thursday, January 2, 2020 2:37 PM EDT
With the United States and China finally making progress in easing the trade war and the Fed supporting growth by keeping rates unchanged in 2020, the U.S. equity market definitely has more room to run.
In this article: TNK, FLGT, CUE, SAVA
Read
All Posts

Latest Tweets for $CUE

No tweets yet!

PARTNER HEADLINES